Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES

Approved

STANDARD

NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES

Laboratoires Grunenthal🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 27, 2020
Approval ID: 47db711b6c75e729
Company: Laboratoires Grunenthal
Type: Standard

Approval Details

Approval Id: 47db711b6c75e729
Drug Cima Aemps Name: NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES
Register Number: 3400935533432
Holder Company Name: Laboratoires Grunenthal
Marketing Company Name: Melyfarma S.L.
Authorization Date: 2020-10-27
Dosage Form: COMPRIMIDO GASTRORRESISTENTE
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratoires Grunenthal

Active Ingredients

ESOMEPRAZOL

20 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 27, 2020

Approval ID

47db711b6c75e729

Type

Standard

Back to CIMA-AEMPS Approvals

NEXIUM MUPS 20 mg COMPRIMIDOS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details